Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trial

Post time 3 day(s) ago

journal：American Heart Journal

Authors：Jung-Min Ahn; Do-Yoon Kang; Pil Hyung Lee; Young-Keun Ahn; Won-Jang Kim; Chang-Wook Nam; Jin-Ok Jeong; In-Ho Chae; Hiroki Shiomi; Paul Hsien Li Kao; Joo-Yong Hahn; Sung-Ho Her; Bong-Ki Lee; Tae Hoon Ahn; Kiyuk Chang; Jei Keon Chae; David Smyth; Gregg W. Stone; Duk-Woo Park; Seung-Jung Park

Published date：2023-10-

DOI：10.1016/j.ahj.2023.05.017

PDF link：https://www.sciencedirect.com/sc ... 002870323001345/pdf

Article link：http://dx.doi.org/10.1016/j.ahj.2023.05.017

Article Source：Elsevier BV。

Remark：

Post time 3 day(s) ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[Elsevier] Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trial

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trial Copy

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trial